Impact of Hydroxocobalamine on Outcome of Smoke Inhalation Injury Admitted to the ICU

CompletedOBSERVATIONAL
Enrollment

739

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

February 1, 2019

Conditions
Smoke Inhalation Patients
Interventions
OTHER

There is no intervention planned (observational)

There is no intervention planned (observational)

Trial Locations (1)

75010

Saint-Louis Hospital, Paris

All Listed Sponsors
lead

Saint-Louis Hospital, Paris, France

OTHER

NCT03558646 - Impact of Hydroxocobalamine on Outcome of Smoke Inhalation Injury Admitted to the ICU | Biotech Hunter | Biotech Hunter